Capital Investment Counsel Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Sell |
10,372
-200
| -2% | -$5.23K | 0.03% | 183 |
|
|
2026
Q1 | $297K | Buy |
10,572
+1,700
| +19% | +$45.3K | 0.04% | 158 |
|
|
2025
Q4 | $221K | Sell |
8,872
-2,600
| -23% | -$65.6K | 0.03% | 187 |
|
|
2025
Q3 | $292K | Sell |
11,472
-1,650
| -13% | -$40.7K | 0.04% | 158 |
|
|
2025
Q2 | $318K | Sell |
13,122
-1,301
| -9% | -$30.3K | 0.04% | 151 |
|
|
2025
Q1 | $365K | Sell |
14,423
-9,230
| -39% | -$242K | 0.05% | 132 |
|
|
2024
Q4 | $628K | Sell |
23,653
-6,696
| -22% | -$182K | 0.09% | 99 |
|
|
2024
Q3 | $878K | Sell |
30,349
-1,433
| -5% | -$41.8K | 0.13% | 90 |
|
|
2024
Q2 | $889K | Sell |
31,782
-13,553
| -30% | -$373K | 0.13% | 85 |
|
|
2024
Q1 | $1.26M | Sell |
45,335
-14,182
| -24% | -$394K | 0.22% | 69 |
|
|
2023
Q4 | $1.71M | Sell |
59,517
-3,963
| -6% | -$120K | 0.3% | 58 |
|
|
2023
Q3 | $2.11M | Hold |
63,480
| – | – | 0.42% | 45 |
|
|
2023
Q2 | $2.33M | Buy |
63,480
+204
| +0.3% | +$7.94K | 0.45% | 42 |
|
|
2023
Q1 | $2.58M | Sell |
63,276
-1,400
| -2% | -$60.5K | 0.59% | 38 |
|
|
2022
Q4 | $3.31M | Buy |
64,676
+20,668
| +47% | +$991K | 0.78% | 29 |
|
|
2022
Q3 | $1.93M | Sell |
44,008
-21,268
| -33% | -$1.03M | 0.56% | 42 |
|
|
2022
Q2 | $3.42M | Sell |
65,276
-361
| -0.5% | -$18.4K | 0.85% | 29 |
|
|
2022
Q1 | $3.4M | Sell |
65,637
-1,400
| -2% | -$72.6K | 0.71% | 32 |
|
|
2021
Q4 | $3.96M | Sell |
67,037
-7,455
| -10% | -$369K | 0.74% | 27 |
|
|
2021
Q3 | $3.2M | Buy |
74,492
+333
| +0.4% | +$14.8K | 0.7% | 32 |
|
|
2021
Q2 | $2.9M | Buy |
74,159
+46,620
| +169% | +$1.81M | 0.65% | 34 |
|
|
2021
Q1 | $998K | Buy |
27,539
+16,502
| +150% | +$586K | 0.27% | 66 |
|
|
2020
Q4 | $406K | Sell |
11,037
-18,305
| -62% | -$671K | 0.13% | 90 |
|
|
2020
Q3 | $1.02M | Buy |
29,342
+17,709
| +152% | +$621K | 0.3% | 51 |
|
|
2020
Q2 | $361K | Sell |
11,633
-16,655
| -59% | -$566K | 0.14% | 87 |
|
|
2020
Q1 | $876K | Buy |
28,288
+2,560
| +10% | +$87.2K | 0.35% | 49 |
|
|
2019
Q4 | $956K | Sell |
25,728
-35
| -0.1% | -$1.25K | 0.31% | 62 |
|
|
2019
Q3 | $878K | Sell |
25,763
-609
| -2% | -$22.1K | 0.31% | 66 |
|
|
2019
Q2 | $1.08M | Buy |
26,372
+983
| +4% | +$39K | 0.39% | 56 |
|
|
2019
Q1 | $1.02M | Buy |
25,389
+527
| +2% | +$21.1K | 0.38% | 54 |
|
|
2018
Q4 | $1.03M | Hold |
24,862
| – | – | 0.45% | 51 |
|
|
2018
Q3 | $1.04M | Sell |
24,862
-557
| -2% | -$21.4K | 0.38% | 60 |
|
|
2018
Q2 | $875K | Sell |
25,419
-1,902
| -7% | -$65K | 0.35% | 67 |
|
|
2018
Q1 | $920K | Buy |
27,321
+88
| +0.3% | +$3.02K | 0.38% | 63 |
|
|
2017
Q4 | $936K | Sell |
27,233
-158
| -0.6% | -$5.39K | 0.39% | 63 |
|
|
2017
Q3 | $928K | Sell |
27,391
-3,277
| -11% | -$105K | 0.4% | 62 |
|
|
2017
Q2 | $977K | Sell |
30,668
-2,402
| -7% | -$75.7K | 0.43% | 59 |
|
|
2017
Q1 | $1.07M | Buy |
33,070
+1,076
| +3% | +$33.9K | 0.48% | 55 |
|
|
2016
Q4 | $986K | Sell |
31,994
-290
| -0.9% | -$8.85K | 0.48% | 55 |
|
|
2016
Q3 | $1.04M | Sell |
32,284
-2,424
| -7% | -$81.1K | 0.52% | 51 |
|
|
2016
Q2 | $1.16M | Sell |
34,708
-106
| -0.3% | -$3.38K | 0.6% | 45 |
|
|
2016
Q1 | $979K | Sell |
34,814
-474
| -1% | -$13.5K | 0.5% | 50 |
|
|
2015
Q4 | $1.08M | Sell |
35,288
-1,107
| -3% | -$34.8K | 0.56% | 47 |
|
|
2015
Q3 | $1.08M | Sell |
36,395
-712
| -2% | -$22.8K | 0.59% | 46 |
|
|
2015
Q2 | $1.18M | Buy |
37,107
+317
| +0.9% | +$10.3K | 0.59% | 51 |
|
|
2015
Q1 | $1.21M | Sell |
36,790
-221
| -0.6% | -$7.03K | 0.57% | 51 |
|
|
2014
Q4 | $1.09M | Sell |
37,011
-1,792
| -5% | -$51.4K | 0.53% | 55 |
|
|
2014
Q3 | $1.09M | Sell |
38,803
-5,692
| -13% | -$160K | 0.54% | 53 |
|
|
2014
Q2 | $1.25M | Sell |
44,495
-2,893
| -6% | -$82.5K | 0.54% | 54 |
|
|
2014
Q1 | $1.44M | Buy |
47,388
+48
| +0.1% | +$1.43K | 0.64% | 49 |
|
|
2013
Q4 | $1.38M | Sell |
47,340
-317
| -0.7% | -$9.23K | 0.62% | 48 |
|
|
2013
Q3 | $1.3M | Sell |
47,657
-2,318
| -5% | -$63.1K | 0.64% | 45 |
|
|
2013
Q2 | $1.33M | Buy |
+49,975
| New | +$1.38M | 0.69% | 38 |
|
Other funds holding PFE
Capital Investment Counsel Inc's PFE Position: Q2 2026 in Review
Capital Investment Counsel Inc reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $5.23K and leaving 10,372 shares worth $250K. The position accounts for 0.03% of the portfolio, ranked #183.
Capital Investment Counsel Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.96M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Capital Investment Counsel Inc held 10,372 shares of Pfizer worth $250K as of Q2 2026.
- Capital Investment Counsel Inc sold 200 Pfizer shares in Q2 2026, an estimated $5.23K.
- Pfizer made up 0.03% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #183 holding.
- Capital Investment Counsel Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Capital Investment Counsel Inc's Pfizer position peaked at $3.96M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.